目的探讨甘油三酯-葡萄糖指数(TyG)与前循环大血管闭塞急性缺血性脑卒中(AIS-LVO)的关系。方法回顾性分析2018年1月至2019年12月在海军军医大学第一附属医院脑血管病中心行急诊血管内取栓治疗的前循环AIS-LVO患者的资料。根据术后90 d改良Rankin量表(mRS)评分将所有患者分为预后良好组(mRS评分为0~2分)和预后不良组(mRS评分为3~6分),比较两组患者的TyG。再根据TyG中位数将患者分为低TyG组(TyG<8.57)和高TyG组(TyG≥8.57),比较两组患者的临床资料、实验室指标及影像学特征。通过ROC曲线评价TyG对预后不良的预测价值。结果共纳入135例患者,其中预后良好组72例,预后不良组63例,预后不良组的TyG高于预后良好组(8.82±0.63 vs 8.43±0.60,P<0.001)。低TyG组67例、高TyG组68例;与低TyG组相比,高TyG组有高脂血症病史的患者比例(P=0.003)、入院时收缩压(P=0.018)、空腹血糖水平(P<0.001)、甘油三酯水平(P<0.001)均更高,核心梗死体积更大(P=0.025),高密度脂蛋白胆固醇水平更低(P=0.013),术后90 d mRS评分也更高[3(1,5)分vs 1(0,5)分,P=0.049]。TyG对前循环AIS-LVO患者预后不良有一定的预测价值(AUC值为0.662,95%CI 0.571~0.753)。结论TyG在预后不良的前循环AIS-LVO患者中升高,可能是前循环AIS-LVO患者的潜在预后指标。
Being a great threaten for human health, obesity has become a pandemic chronic disease. There have been several therapeutic treatments for this social health issue, including diet and exercise therapy, medication and ...
详细信息
Being a great threaten for human health, obesity has become a pandemic chronic disease. There have been several therapeutic treatments for this social health issue, including diet and exercise therapy, medication and surgery, among which the diet is still the most common way. However, none of these therapeutic measures available is ideal, making it necessary to find an effective medical treatment. The endocannabinoid system, which is well known for its contributions in certain mental processes such as relaxation, amelioration of pain and anxiety, and sedation initiation, has been recently reported to play an essential role in regulating appetite and metabolism to maintain energy balance, leading to the belief that endocannabinoid system is closely related to obesity. This new discovery deepens our understanding of obesity, and provides us with a new direction for clinical obesity treatment. Rimonabant is an antagonist for CB1, and has entered the market in some countries. However, although effective as an anti-obesity drug, rimonabant also causes obviously adverse side-effects, thus is being doubted and denied for medical usage.
暂无评论